首页> 外文期刊>World Journal of Gastroenterology >Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis.
【24h】

Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis.

机译:小儿非酒精性脂肪性肝炎肝纤维化的非侵入性评估。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To identify the independent predictors of hepatic fibrosis in 69 children with nonalcoholic steatohepatitis (NASH) due to nonalcoholic fatty liver disease (NAFLD). METHODS: All patients with clinically suspected NASH underwent liver biopsy as a confirmatory test. The following clinical and biochemical variables at baseline were examined as likely predictors of fibrosis at histology: age, body mass index (BMI), systolic blood pressure (SBP), dyastolic blood pressure (DBP), fasting glucose, fasting insulin, homeostatic model assessment for insulin resistence (HOMA-IR), cholesterol, tryglicerides, alanine aminotransferase (ALT), aspartate aminotransferase (AST), AST/ALT ratio, gamma glutamil transferase (GT), platelet count, prothrombin time (PT). RESULTS: At histology 28 (40.6%) patients had no fibrosis and 41 (59.4%) had mild to bridging fibrosis. At multivariate analysis, BMI > 26.3 was the only independent predictor of fibrosis (OR = 5.85, 95% CI = 1.6-21). CONCLUSION: BMI helps identify childrenwith NASH who might have fibrotic deposition in the liver.
机译:目的:确定69例非酒精性脂肪性肝病(NAFLD)引起的非酒精性脂肪性肝炎(NASH)患儿肝纤维化的独立预测因子。方法:所有临床怀疑为NASH的患者均进行了肝活检以作为确证性检查。在基线时检查了以下临床和生化变量,作为组织学纤维化的可能预测指标:年龄,体重指数(BMI),收缩压(SBP),舒张压(DBP),空腹血糖,空腹胰岛素,稳态模型评估用于胰岛素抵抗(HOMA-IR),胆固醇,Tryglicerides,丙氨酸氨基转移酶(ALT),天冬氨酸氨基转移酶(AST),AST / ALT比,γ谷氨酰胺转移酶(GT),血小板计数,凝血酶原时间(PT)。结果:在组织学上,28例(40.6%)无纤维化,41例(59.4%)轻度至桥接纤维化。在多变量分析中,BMI> 26.3是纤维化的唯一独立预测因子(OR = 5.85,95%CI = 1.6-21)。结论:BMI有助于鉴别出可能患有肝纤维化沉积的NASH患儿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号